These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Neurochemical aspects of parkinsonism. Review of the literature]. De Mattos JP, Cechela C, Adams JG, De Lima JM. Arq Neuropsiquiatr; 1982 Sep; 40(3):289-95. PubMed ID: 6130754 [Abstract] [Full Text] [Related]
5. Serotonergic neurones are not involved in action of L-dopa in Parkinson's disease. Melamed E, Hefti F, Liebman J, Schlosberg AJ, Wurtman RJ. Nature; 1980 Feb 21; 283(5749):772-4. PubMed ID: 6101905 [No Abstract] [Full Text] [Related]
6. [Biochemical aspects of involuntary movements (author's transl)]. Nakamura S, Kameyama M. No To Shinkei; 1981 Dec 21; 33(12):1177-85. PubMed ID: 7034752 [No Abstract] [Full Text] [Related]
7. Biochemical neuropathology of Parkinson's disease. Javoy-Agid F, Ruberg M, Taquet H, Bokobza B, Agid Y, Gaspar P, Berger B, N'Guyen-Legros J, Alvarez C, Gray F. Adv Neurol; 1984 Dec 21; 40():189-98. PubMed ID: 6695594 [No Abstract] [Full Text] [Related]
8. Dopaminergic nervous transmission in Parkinson's disease. Rinne UK, Sonninen V, Riekkinen P, Laaksonen H. Med Biol; 1974 Jun 21; 52(3):208-17. PubMed ID: 4371255 [No Abstract] [Full Text] [Related]
9. [Abnormalities of catecholamine metabolism in Parkinson's disease (author's transl)]. Nagatsu T. Tanpakushitsu Kakusan Koso; 1981 Aug 21; 26(11):1781-8. PubMed ID: 6117927 [No Abstract] [Full Text] [Related]
10. Experimentally induced parkinsonism. Poirier LJ, Sourkes TL. Res Publ Assoc Res Nerv Ment Dis; 1972 Aug 21; 50():416-33. PubMed ID: 4403656 [No Abstract] [Full Text] [Related]
11. Rational approaches to the pharmacotherapy of chorea. Chase TN. Res Publ Assoc Res Nerv Ment Dis; 1976 Aug 21; 55():337-50. PubMed ID: 137504 [No Abstract] [Full Text] [Related]
13. The neurochemistry of Parkinson's disease: effect of L-dopa therapy. Lloyd KG, Davidson L, Hornykiewicz O. J Pharmacol Exp Ther; 1975 Dec 21; 195(3):453-64. PubMed ID: 489 [Abstract] [Full Text] [Related]
14. Familial fatal Parkinsonism with alveolar hypoventilation and mental depression. Purdy A, Hahn A, Barnett HJ, Bratty P, Ahmad D, Lloyd KG, McGeer EG, Perry TL. Ann Neurol; 1979 Dec 21; 6(6):523-31. PubMed ID: 43704 [Abstract] [Full Text] [Related]
15. CNS compensation to dopamine neuron loss in Parkinson's disease. Lloyd KG. Adv Exp Med Biol; 1977 Dec 21; 90():255-66. PubMed ID: 930746 [Abstract] [Full Text] [Related]
16. Enzymes associated with the metabolism of catecholamines, acetylcholine and gaba in human controls and patients with Parkinson's disease and Huntington's chorea. McGeer PL, McGeer EG. J Neurochem; 1976 Jan 21; 26(1):65-76. PubMed ID: 3629 [No Abstract] [Full Text] [Related]
17. [Dopamine agonists in the therapy of parkinson syndrome]. Kapfhammer HP, Rüther E. Nervenarzt; 1985 Feb 21; 56(2):69-81. PubMed ID: 3982566 [No Abstract] [Full Text] [Related]
18. Brain dopamine and noradrenaline in 3 Parkinsonians deceased during L-dopa treatment. Buscaino GA, Jori A, Campanella G. Acta Neurol (Napoli); 1972 Feb 21; 27(6):537-44. PubMed ID: 4651485 [No Abstract] [Full Text] [Related]
19. Dopaminephilic properties of ergot alkaloids. Goldstein M, Lew JY, Nakamura S, Battista AF, Lieberman A, Fuxe K. Fed Proc; 1978 Jun 21; 37(8):2202-6. PubMed ID: 26607 [No Abstract] [Full Text] [Related]
20. Ultrastructural chemoanatomy of the basal ganglia: an overview. Pasik P, Pasik T, Holstein GR. Adv Neurol; 1987 Jun 21; 45():59-66. PubMed ID: 2881451 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]